Financials
- Market Capitalization 319.4 M
- Employee 106
- Founded 2015
- CEO N/A
- Website www.foghorntx.com
- Headquarter Delaware, United States
- FIGI BBG00HFZPB88
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3249 | ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.62 USD | -5.33% | -1.49% | +19.07% | +237.23% | 328.88 M USD | ||
| 3252 | PALI Palisade Bio, Inc. - Common Stock | 1.89 USD | -3.57% | -12.90% | +9.25% | +11.18% | 328.07 M USD | ||
| 3316 | IRD Opus Genetics, Inc. - Common Stock | 3.81 USD | -2.81% | -7.30% | -7.52% | +2.42% | 310.12 M USD | ||
| 3319 | EDIT Editas Medicine, Inc. - Common Stock | 3.16 USD | -3.07% | -13.42% | +24.90% | +9.72% | 309.38 M USD |
Frequently asked questions about Foghorn Therapeutics Inc. - Common Stock
What is the Foghorn Therapeutics Inc. - Common Stock stock price today?
The current price of Foghorn Therapeutics Inc. - Common Stock (FHTX) is 5.44. Over the past 24 hours, the stock has changed by -8.57%. Follow the FHTX chart for real-time price dynamics.
What is the stock ticker of Foghorn Therapeutics Inc. - Common Stock?
Foghorn Therapeutics Inc. - Common Stock trades under the ticker FHTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Foghorn Therapeutics Inc. - Common Stock stock going up?
FHTX has changed by +7.72% over the last week, +28.30% over the last month, and +33.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Foghorn Therapeutics Inc. - Common Stock net income for the last quarter?
Foghorn Therapeutics Inc. - Common Stock reported net income of -19.88 M for the last quarter. The previous quarter showed -21.66 M, which means net income changed by +8.26%.
How many employees does Foghorn Therapeutics Inc. - Common Stock have?
As of the latest available data, Foghorn Therapeutics Inc. - Common Stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is Foghorn Therapeutics Inc. - Common Stock EBITDA?
Foghorn Therapeutics Inc. - Common Stock EBITDA is -21.34 M, and its EBITDA margin is -653.05%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Foghorn Therapeutics Inc. - Common Stock stock?
You can buy Foghorn Therapeutics Inc. - Common Stock (FHTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Foghorn Therapeutics Inc. - Common Stock stock?
Investing in Foghorn Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FHTX chart and related analysis on metatrader.com as part of your research.